Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study José Rosas; Francisco Pasquau Liaño; Mónica Llombart Cantó; José María Carrasco Barea; Amparo Raga Beser; José Tomás Algado Rabasa; Francisco Martínez Adsuar; Brian Vila Auli; Isabel Fernández López; Ana María Garijo Sainz; Pere Esquerdo Ramis; Laura Ruiz Pérez; Mª Luisa Navarrete Rebollo; Raquel Hernández Lorido; Laura Gómez Escolar;

Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection Montserrat Robustillo-Villarino; Laura Álvarez-Arroyo; Francisco Javier Carrera-Hueso; Inés Barreda-Altaba; María Nieto-Cid; Ana María Girona-Sanz; David El-Qutob;

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;